Search research articles
Contact Us
Filters
Showing results (171-180 of 180) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 180 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Amro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
British Journal of Clinical Pharmacology
|
January 5, 2022
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients
Frank M P van Haren, Lex M van Loon, Anne Steins, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
British Journal of Clinical Pharmacology
|
December 30, 2020
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies
Frank M P van Haren, Alice Richardson, Hwan-Jin Yoon, et al.
Hepatology Communications
|
November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga
Scott M Thompson, Garima Suman, Michael S Torbenson, et al.
Annals of Surgery
|
October 20, 2023
An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure
Jonas Santol, Sarang Kim, Lindsey A Gregory, et al.
Cancer Discovery
|
June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
Gadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Eclinicalmedicine
|
November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studies
Frank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
Annals of Surgery
|
August 2, 2021
Perihilar Cholangiocarcinoma - Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers
Matteo Mueller, Eva Breuer, Takashi Mizuno, et al.
Hepatology (Baltimore, Md.)
|
February 2, 2026
Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses
Younghun Han, Jinyoung Byun, Caitlin J VanLith, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 180) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 180 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Amro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
British Journal of Clinical Pharmacology
|
January 5, 2022
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients
Frank M P van Haren, Lex M van Loon, Anne Steins, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
British Journal of Clinical Pharmacology
|
December 30, 2020
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies
Frank M P van Haren, Alice Richardson, Hwan-Jin Yoon, et al.
Hepatology Communications
|
November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga
Scott M Thompson, Garima Suman, Michael S Torbenson, et al.
Annals of Surgery
|
October 20, 2023
An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure
Jonas Santol, Sarang Kim, Lindsey A Gregory, et al.
Cancer Discovery
|
June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
Gadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Eclinicalmedicine
|
November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studies
Frank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
Annals of Surgery
|
August 2, 2021
Perihilar Cholangiocarcinoma - Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers
Matteo Mueller, Eva Breuer, Takashi Mizuno, et al.
Hepatology (Baltimore, Md.)
|
February 2, 2026
Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses
Younghun Han, Jinyoung Byun, Caitlin J VanLith, et al.
Page
of 18